Introduction

Klebsiella sp. is a genus of Gram-negative bacteria that exists as a complex part of the human microbial landscape. While often recognized in clinical settings as an opportunistic pathogen, it is also found as a commensal in various niches of the human body. Understanding the balance of Klebsiella sp. within the gut ecosystem and other mucosal sites is essential for maintaining overall health and preventing the progression toward dysbiosis.

Location of Microbe

Gut Ecosystem

In the gut, Klebsiella sp. resides within the intestinal tract, where it contributes to the overall microbial abundance of the Enterobacteriaceae family.

Oral Ecosystem

Within the oral cavity, specifically the oropharynx, Klebsiella sp. exists as part of the commensal microbiota, occupying niches in the posterior pharynx and tonsil crypts.

Respiratory Ecosystem

In the respiratory tract, Klebsiella sp. can be found in the lungs and bronchial airways, often mirroring the populations present in the oral reservoir.

Urinary Ecosystem

In the urinary tract, Klebsiella sp. can colonize the bladder and ureters, often originating from other mucosal sites in the body.

Behavior During Dysbiosis

Ecosystem Shifts

Gut: During dysbiosis, such as in colorectal cancer, there is a significant elevation in the abundance of specific strains like Klebsiella sp. LTGPAF-6F.
Oral: In the context of COVID-19, an increased ratio of Klebsiella sp. is observed, correlating with higher systemic inflammation markers.
Respiratory: Shifts in the respiratory microbiome often involve an overgrowth of Klebsiella sp., which may migrate from the oral cavity to induce co-infections.
Urinary: Dysbiosis in the urinary tract is characterized by the proliferation of Klebsiella sp., frequently leading to high antibiotic resistance patterns in clinical isolates.

Disease Associations

Gut Ecosystem Associations

In the gut, Klebsiella sp. is significantly associated with stage III colorectal cancer (CRC). Research indicates that populations of Klebsiella sp. LTGPAF-6F are elevated in CRC patients compared to healthy individuals, coinciding with a general reduction in overall microbial diversity. Furthermore, the presence of ESBL-coding genes, such as blaOXY, in Klebsiella sp. within the gut has been monitored during H. pylori eradication therapy, where these organisms can act as reservoirs for antimicrobial resistance genes.

Oral and Respiratory Ecosystem Associations

In the oropharynx, increased ratios of Klebsiella sp. are associated with increased COVID-19 severity and elevated systemic inflammation markers, such as the neutrophil–lymphocyte ratio (NLR). Because the oral cavity serves as a natural reservoir, these microbes are often linked to co-infections in the lungs, contributing to hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) in critically ill patients.

Urinary Ecosystem Associations

In the urinary tract, Klebsiella sp. is a predominant pathogen associated with urinary tract infections (UTIs). It is frequently identified in hospital-acquired infections among critically ill patients, often exhibiting high levels of antimicrobial resistance, including the production of extended-spectrum beta-lactamases (ESBL), which limits effective therapeutic options.

Foods Supporting Healthy Balance

Maintaining a balanced gut ecosystem is key to preventing the overgrowth of opportunistic pathogens like Klebsiella sp. A diet rich in diverse prebiotic fibers—such as inulin and fructooligosaccharides found in garlic, onions, and asparagus—supports the growth of beneficial commensals that compete with Klebsiella sp. for resources. Incorporating fermented foods like kefir, sauerkraut, and kimchi introduces beneficial lactic acid bacteria, which help maintain the gut barrier integrity and regulate inflammatory signaling. Reducing the intake of highly processed sugars and refined carbohydrates is also crucial, as excessive simple sugars can fuel the expansion of certain Proteobacteria, potentially leading to dysbiosis. A focus on a Mediterranean-style diet, emphasizing omega-3 fatty acids from fatty fish and polyphenols from berries and nuts, helps modulate the host-microbe interaction and supports a stable, diverse microbial community.

Actionable Insights

• Prioritize Fiber Diversity: Consume a wide variety of plant-based fibers to support microbial diversity and prevent the competitive dominance of Klebsiella sp. in the gut.
• Probiotic Integration: Incorporate fermented foods to help maintain a balanced gut ecosystem and strengthen the mucosal barrier.
• Antibiotic Stewardship: Use antibiotics only when strictly necessary and under medical supervision to prevent the selection of ESBL-coding strains of Klebsiella sp.
• Oral Hygiene: Maintain regular oral care to reduce the reservoir of opportunistic pathogens in the oropharynx, potentially lowering the risk of respiratory co-infections.
• Urinary Health: Ensure adequate hydration and practice proper hygiene to reduce the likelihood of Klebsiella sp. colonization and subsequent urinary tract infections.
• Inflammation Management: Focus on an anti-inflammatory diet rich in antioxidants to mitigate the systemic inflammation associated with microbial imbalances.

Conclusion

The impact of Klebsiella sp. on human health is highly dependent on the specific strain and the niche context in which it resides. In the gut, it can be associated with colorectal cancer and serve as a reservoir for resistance genes. In the oral and respiratory ecosystems, it acts as a potential driver of inflammation and co-infection, while in the urinary tract, it often manifests as a resistant pathogen. By focusing on microbial diversity and ecosystem health through diet and mindful hygiene, it is possible to manage the abundance of this organism and maintain a balanced host-microbe interaction across all these critical environments.